What's New with VISs
This page offers the latest information about vaccine information statements currently under development or newly released.
March 21, 2018
An updated Vaccine Information Statement for anthrax vaccine has been posted on March 21, 2018. It may be used starting immediately.
February 23, 2018
The rotavirus VIS has been updated to replace an outdated link to information about porcine circovirus. No other changes have been made to the VIS. While we encourage providers to begin using the updated VIS as soon as possible, stocks of the previous edition may still be used until exhausted.
February 12, 2018
A Vaccine Information Statement for recombinant zoster vaccine has been posted on February 12, 2018 and may be used starting immediately.
Also, updated VISs for live zoster vaccine, MMR, MMRV, and varicella have been posted. We encourage providers to begin using these VISs immediately, but stocks of the previous editions may be used until exhausted.
July 6, 2017
A Vaccine Information Statement for cholera vaccine has been posted on July 6, 2017. It may be used starting immediately.
May 8, 2017
Now that Gardasil-4 is no longer available for use in the United States since the last doses expired on May 1, 2017, the Gardasil-4 VIS has been removed from website. Providers should use the Gardasil-9 VIS when administering HPV vaccine.
April 11, 2017
The Td VIS has been updated to correct an error. The first bullet under the “Talk to your doctor . . .” part of Section 3 (“have seizures or another nervous system problem”) has been removed. This precaution applies to Tdap vaccine, but not to Td. Providers who continue to use up existing stocks of the outgoing (2/24/2015) VIS should be aware that this is NOT a precaution for Td.
December 2, 2016
An updated VIS for Gardasil-9 has been released, containing information about the recently-approved 2-dose schedule. Otherwise, it is the same as the existing Gardasil-9 VIS. While this updated VIS should ideally begin to be used now, existing stocks of the current VIS may continue to be used, particularly for patients using the 3-dose schedule.
Note that the VIS no longer specifies “Gardasil-9.” This is because Gardasil-9 will soon be the only HPV vaccine available in the U.S., as Cervarix and Gardasil (quadrivalent HPV vaccine) will no longer be sold in the United States. The appropriate VISs should continue to be used for those two vaccines as long as unexpired doses remain available.
August 9, 2016
An updated edition of the MenB vaccine VIS has been posted. This VIS is now final, as opposed to interim, edition. While we encourage providers to begin using this VIS immediately, stocks of the previous edition may still be used until exhausted.
August 3, 2016
Flu VISs are no longer updated every year. The edition dated 8/7/2015 should be used for the current flu season.
July 20, 2016
Updated editions of the hepatitis A, hepatitis B, and polio vaccine VISs have been posted. These VISs are now final, as opposed to interim, editions. While we encourage providers to begin using these VISs immediately, stocks of the previous editions may still be used until exhausted.
March 31, 2016
Updated editions of the Meningococcal (quadrivalent, ACWY) and HPV-9 VISs have been posted. Neither differs significantly from the existing VIS, but both are now final, as opposed to interim, editions. We encourage providers to begin using these VISs immediately, but stocks of the previous editions may still be used until exhausted.
- Page last reviewed: July 11, 2018
- Page last updated: July 11, 2018
- Content source: